APA (7th ed.) Citation

Worapong Nasomsong, Parnrada Nulsopapon, Dhitiwat Changpradub, Supanun Pungcharoenkijkul, Patomroek Hanyanunt, Tassanawan Chatreewattanakul, & Wichai Santimaleeworagun. (2022). Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>. MDPI AG.

Chicago Style (17th ed.) Citation

Worapong Nasomsong, Parnrada Nulsopapon, Dhitiwat Changpradub, Supanun Pungcharoenkijkul, Patomroek Hanyanunt, Tassanawan Chatreewattanakul, and Wichai Santimaleeworagun. Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas Aeruginosa</i>. MDPI AG, 2022.

MLA (9th ed.) Citation

Worapong Nasomsong, et al. Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas Aeruginosa</i>. MDPI AG, 2022.